On Oct. 24, the American Hospital Association (AHA) responded to Office of the National Coordinator for Health IT (ONC) in a letter that asks for more details about how the organization will assess readiness and implementation specifications.

Researchers testing the effect of a new biologic medication on patients with multidrug resistant HIV have found that the drug caused 83 percent of participants to experience a virologic response. The drug is delivered intravenously once every two weeks, raising the rates of medication adherence and further reducing the chances of passing on the infection.

Researchers from Baylor College of Medicine, Texas Children’s Hospital and Johns Hopkins University School of Medicine believe that a preventative pill for Alzheimer’s could be the solution in stopping this devastating disease.

Tracking your steps isn’t the only thing mobile applications are able to monitor. Researchers from Cardiff University in Wales studied the effects of mobile apps on helping people with diabetes. Turns out, the technology may be a valuable option in helping track glucose levels.

NASHVILLE, Tenn. and TAMPA, Fla., Oct. 27, 2016 -- By 2025, chronic diseases may affect an estimated 164 million Americans – nearly half of the current U.S. population. To address this looming crisis, WellCare Health Plans, Inc. (NYSE: WCG) is piloting an in-home telemonitoring program for its Medicare Advantage members with chronic conditions in Tennessee, Arkansas and Mississippi. The pilot will include up to 500 members diagnosed with congestive heart failure and diabetes. 

After Mylan created a firestorm with huge price increases for its anti-allergy EpiPen, it's now set to have a competitor in 2017.

Facebook has become the most popular social network in the world, with more than 1.7 billion accounts, and researchers at the University of Cambridge believe the site can help identify mental illness and even be used to treat it.

Prepare to taste the rich joy of peanut butter, kids! Researchers have developed a wearable patch that administers a small amount of peanut protein through the skin to treat peanut allergies in children and young adults.